These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8784455)

  • 1. Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinity.
    Zhang Y; Williams W; Bowen WD; Rice KC
    J Med Chem; 1996 Aug; 39(18):3564-8. PubMed ID: 8784455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and receptor binding properties of fluoro- and iodo-substituted high affinity sigma receptor ligands: identification of potential PET and SPECT sigma receptor imaging agents.
    de Costa B; Radesca L; Dominguez C; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jun; 35(12):2221-30. PubMed ID: 1319493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds.
    de Costa BR; He XS; Linders JT; Dominguez C; Gu ZQ; Williams W; Bowen WD
    J Med Chem; 1993 Aug; 36(16):2311-20. PubMed ID: 8360875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor.
    de Costa BR; Radesca L; Di Paolo L; Bowen WD
    J Med Chem; 1992 Jan; 35(1):38-47. PubMed ID: 1310114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes.
    de Costa BR; He XS; Dominguez C; Cutts J; Williams W; Bowen WD
    J Med Chem; 1994 Jan; 37(2):314-21. PubMed ID: 8295220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands.
    Zhang Y; Williams W; Torrence-Campbell C; Bowen WD; Rice KC
    J Med Chem; 1998 Dec; 41(25):4950-7. PubMed ID: 9836612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
    Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
    Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice.
    Matsumoto RR; Gilmore DL; Pouw B; Bowen WD; Williams W; Kausar A; Coop A
    Eur J Pharmacol; 2004 May; 492(1):21-6. PubMed ID: 15145701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
    Bowen WD; Walker JM; de Costa BR; Wu R; Tolentino PJ; Finn D; Rothman RB; Rice KC
    J Pharmacol Exp Ther; 1992 Jul; 262(1):32-40. PubMed ID: 1320690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.
    He XS; Bowen WD; Lee KS; Williams W; Weinberger DR; de Costa BR
    J Med Chem; 1993 Mar; 36(5):566-71. PubMed ID: 8496936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.
    Vangveravong S; Xu J; Zeng C; Mach RH
    Bioorg Med Chem; 2006 Oct; 14(20):6988-97. PubMed ID: 16837201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of kappa opioid receptors in mouse microglial cells.
    Chang AC; Chao CC; Takemori AE; Gekker G; Hu S; Peterson PK; Portoghese PS
    J Med Chem; 1996 Apr; 39(8):1729-35. PubMed ID: 8648612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of sigma receptor ligands with unsymmetrical spiro connection of the piperidine moiety.
    Jasper A; Schepmann D; Lehmkuhl K; Vela JM; Buschmann H; Holenz J; Wünsch B
    Eur J Med Chem; 2009 Nov; 44(11):4306-14. PubMed ID: 19709783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
    Matsumoto RR; McCracken KA; Pouw B; Miller J; Bowen WD; Williams W; De Costa BR
    Eur J Pharmacol; 2001 Jan; 411(3):261-73. PubMed ID: 11164383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.
    Waterhouse RN; Mardon K; Giles KM; Collier TL; O'Brien JC
    J Med Chem; 1997 May; 40(11):1657-67. PubMed ID: 9171875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies.
    Matsumoto RR; Potelleret FH; Mack A; Pouw B; Zhang Y; Bowen WD
    Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
    Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
    J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.